Status:
COMPLETED
The Mechanism of Sox4 Transcription in Regulation of Angiogenesis in Hepatocellular Carcinoma
Lead Sponsor:
Chang Gung Memorial Hospital
Collaborating Sponsors:
Ministry of Science and Technology, Taiwan
Conditions:
Translational Research of SOX4 in Hepatocellular Carcinoma
Eligibility:
All Genders
20-85 years
Brief Summary
Two hundred HCC patients with partial hepatectomy were enrolled as a cohort for observational study. The inclusion criterion was intended curative hepatectomy for HCC patients by image analysis, and t...
Detailed Description
To determine the role of SOX4 in tumor progression in patients with HCC, we examined SOX4 expression through immunohistochemistry (IHC) staining of 200 formalin-fixed and paraffin-embedded (FFPE) HCC ...
Eligibility Criteria
Inclusion
- subjects with pathologic diagnosis of hepatocellular carcinoma and curative partial hepatectomies -
Exclusion
- history of different malignant disease, subject cannot be treated with curative surgery -
Key Trial Info
Start Date :
January 8 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 31 2019
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04296058
Start Date
January 8 2007
End Date
March 31 2019
Last Update
March 5 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.